Three-year follow-up on effects of transdermal estrogen [1]

Annals of Internal Medicine

Volumn 125, Issue 1, 1996, Pages 77-

  Lufkin, E G ^a   Riggs, B L ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ALKALINE PHOSPHATASE; ESTROGEN; ETIDRONIC ACID; HYDROXYPROLINE; OSTEOCALCIN; PAMIDRONIC ACID; PROGESTERONE;

ALKALINE PHOSPHATASE BLOOD LEVEL; BONE DENSITY; BONE MINERALIZATION; BONE REMODELING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYDROXYPROLINE URINE LEVEL; LETTER; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; TRANSDERMAL DRUG ADMINISTRATION; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 17644429643     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-125-1-199607010-00014     Document Type: Letter

References (5)